Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes

Jelena Kravarusic; Grazia Aleppo

doi:10.1016/j.ecl.2019.10.006

Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes

Jelena Kravarusic, Grazia Aleppo^*

^*Corresponding author for this work

Medicine, Endocrinology Division

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Abstract

In the last 2 decades, diabetes technology has emerged as a branch of diabetes management thanks to the advent of continuous glucose monitoring (CGM) and increased availability of continuous subcutaneous insulin infusion systems, or insulin pumps. These tools have progressed from rudimentary instruments to sophisticated therapeutic options for advanced diabetes management. This article discusses the available CGM and insulin pump systems and the clinical benefits of their use in adults with type 1 diabetes, intensively insulin-treated type 2 diabetes, and pregnant patients with preexisting diabetes.

Original language	English (US)
Pages (from-to)	37-55
Number of pages	19
Journal	Endocrinology and Metabolism Clinics of North America
Volume	49
Issue number	1
DOIs	https://doi.org/10.1016/j.ecl.2019.10.006
State	Published - Mar 2020

Keywords

Continuous glucose monitoring (CGM)
Continuous subcutaneous insulin infusion (CSII)
Hybrid closed loop
Patch pump
Sensor-augmented pump (SAP)

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ecl.2019.10.006

Cite this

@article{8261d472223c4538bacc851172e4eb5d,

title = "Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes",

abstract = "In the last 2 decades, diabetes technology has emerged as a branch of diabetes management thanks to the advent of continuous glucose monitoring (CGM) and increased availability of continuous subcutaneous insulin infusion systems, or insulin pumps. These tools have progressed from rudimentary instruments to sophisticated therapeutic options for advanced diabetes management. This article discusses the available CGM and insulin pump systems and the clinical benefits of their use in adults with type 1 diabetes, intensively insulin-treated type 2 diabetes, and pregnant patients with preexisting diabetes.",

keywords = "Continuous glucose monitoring (CGM), Continuous subcutaneous insulin infusion (CSII), Hybrid closed loop, Patch pump, Sensor-augmented pump (SAP)",

author = "Jelena Kravarusic and Grazia Aleppo",

note = "Funding Information: J. Kravarusic has nothing to disclose. G. Aleppo has received research support to her employer from Novo Nordisk (Denmark), Eli Lilly (United States), and Dexcom. G. Aleppo reports consulting for Dexcom, Insulet, and Medtronic. Funding Sources: None. Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = mar,

doi = "10.1016/j.ecl.2019.10.006",

language = "English (US)",

volume = "49",

pages = "37--55",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes

AU - Kravarusic, Jelena

AU - Aleppo, Grazia

N1 - Funding Information: J. Kravarusic has nothing to disclose. G. Aleppo has received research support to her employer from Novo Nordisk (Denmark), Eli Lilly (United States), and Dexcom. G. Aleppo reports consulting for Dexcom, Insulet, and Medtronic. Funding Sources: None. Publisher Copyright: © 2019 Elsevier Inc.

PY - 2020/3

Y1 - 2020/3

N2 - In the last 2 decades, diabetes technology has emerged as a branch of diabetes management thanks to the advent of continuous glucose monitoring (CGM) and increased availability of continuous subcutaneous insulin infusion systems, or insulin pumps. These tools have progressed from rudimentary instruments to sophisticated therapeutic options for advanced diabetes management. This article discusses the available CGM and insulin pump systems and the clinical benefits of their use in adults with type 1 diabetes, intensively insulin-treated type 2 diabetes, and pregnant patients with preexisting diabetes.

AB - In the last 2 decades, diabetes technology has emerged as a branch of diabetes management thanks to the advent of continuous glucose monitoring (CGM) and increased availability of continuous subcutaneous insulin infusion systems, or insulin pumps. These tools have progressed from rudimentary instruments to sophisticated therapeutic options for advanced diabetes management. This article discusses the available CGM and insulin pump systems and the clinical benefits of their use in adults with type 1 diabetes, intensively insulin-treated type 2 diabetes, and pregnant patients with preexisting diabetes.

KW - Continuous glucose monitoring (CGM)

KW - Continuous subcutaneous insulin infusion (CSII)

KW - Hybrid closed loop

KW - Patch pump

KW - Sensor-augmented pump (SAP)

UR - http://www.scopus.com/inward/record.url?scp=85076518042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076518042&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2019.10.006

DO - 10.1016/j.ecl.2019.10.006

M3 - Review article

C2 - 31980120

AN - SCOPUS:85076518042

SN - 0889-8529

VL - 49

SP - 37

EP - 55

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 1

ER -

Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this